Internal quality control of PCR-based genotyping methods in research studies and patient diagnostics

Thrombosis and Haemostasis

Volumn 87, Issue 5, 2002, Pages 812-816

  Bladbjerg, Else Marie ^a   Gram, Jørgen ^a   Jespersen, Jørgen ^a   De Maat, Moniek P M ^a  

^a ESBJERG HOSPITAL   (Denmark)

Author keywords

DNA analyses; Haemostasis; PCR; Polymorphism; Quality control

Indexed keywords

AMMONIUM ACETATE; DNA; EDETIC ACID; RESTRICTION ENDONUCLEASE;

ALLELE; ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CLINICAL LABORATORY; CLINICAL RESEARCH; DATA ANALYSIS; DATA BASE; DIAGNOSTIC TEST; DNA ISOLATION; DNA RESTRICTION; ELECTROPHORESIS; ENZYMATIC DEGRADATION; EVALUATION; GENE AMPLIFICATION; GENE DELETION; GENE INSERTION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HEMOSTASIS; HUMAN; POLYMERASE CHAIN REACTION; PRECIPITATION; PRIORITY JOURNAL; QUALITY CONTROL; READING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THROMBOSIS;

EID: 0036247650     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613089     Document Type: Article

References (30)

1. External quality assessment of molecular biology-based methods used in laboratories of clinical chemistry and human genetics
2. Experiences with external quality assessment (EQA) in molecular diagnostics in clinical laboratories in Germany
3. Quality control in molecular genetic testing
4. Multicenter evaluation of PCR methods for the detection of factor V Leiden (R506Q) genotypes
5. A UK National Quality Assessment Scheme (UK Neqas) for molecular genetic testing for the diagnosis of familial thrombophilia
6. Quality assurance in molecular genetic testing laboratories
7. Quality assessment of haemostatic assays and external quality assessment schemes
8. Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics
9. Standardization and quality control of PCR analyses
10. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease
11. Mutation in blood coagulation factor V associated with resistance to activated protein C
12. Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma
13. A common genetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
14. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals
15. Factor VII polymorphisms in populations with different risks of cardiovascular disease
16. Variation in the promoter region of the β fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers
17. Association of the 1-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation
18. Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue
19. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis
20. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary heart disease
21. The 536C→T transition in the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis
22. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease
23. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis
24. Phenotyping and genotyping of coagulation factor V Leiden
25. Rapid detection of the prothrombin 20210 A variation by allele specific PCR
26. Allelic dimorphism in the human tissue-type plasminogen activator (TPA) gene as a result of an Alu insertion/deletion event
27. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease
28. Mistyping frequency of the angiotensin-converting enzyme gene polymorphism and an improved method for its avoidance
29. Evaluation of a tissue factor dependent factor V assay to detect factor V Leiden: Demonstration of high sensitivity and specificity for a generally applicable assay for activated protein C resistance
30. Genotyping errors with the polymerase chain reaction